Загрузка...
Roundtable: How I treat a newly diagnosed patient with high-risk myeloma
Initial management of high-risk myeloma remains a treatment challenge. Risk is defined by a combination of clinical and biological features, with fluorescence in situ hybridization detection of specific cytogenetic abnormalities driving categorization. High-risk abnormalities include t(4;14), t(14;1...
Сохранить в:
| Опубликовано в: : | Hematology Am Soc Hematol Educ Program |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913472/ https://ncbi.nlm.nih.gov/pubmed/31808841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000015 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|